Up-regulation of Th17 cells may underlie inhibition of Treg development caused by immunization with activated syngeneic T cells

scientific article

Up-regulation of Th17 cells may underlie inhibition of Treg development caused by immunization with activated syngeneic T cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2011PLoSO...627289W
P356DOI10.1371/JOURNAL.PONE.0027289
P932PMC publication ID3210778
P698PubMed publication ID22087281
P5875ResearchGate publication ID51800473

P2093author name stringZhou Zhou
Li Wang
Yue Sun
Baihua Shen
Jinpiao Lin
Ningli Li
Rongfen Huo
P2860cites workT helper 17 cells promote cytotoxic T cell activation in tumor immunityQ24646584
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsQ27860460
Transforming growth factor-beta induces development of the T(H)17 lineageQ28237370
IL-23 promotes tumour incidence and growthQ28239522
TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cellsQ28296956
IL-23 drives a pathogenic T cell population that induces autoimmune inflammationQ29547525
The regulation of IL-10 production by immune cellsQ29615479
Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism.Q52014124
Chemokines and the arrest of lymphocytes rolling under flow conditions.Q52040689
Quantitative analysis of chemokine expression by dendritic cell subsets in vitro and in vivoQ73894243
The plasticity of dendritic cell responses to pathogens and their componentsQ77069892
Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cellsQ78806915
Immunization with autologous T cells enhances in vivo anti-tumor immune responses accompanied by up-regulation of GADD45betaQ79853276
Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cellsQ80466965
The prevalence of Th17 cells in patients with gastric cancerQ81700421
TGF-beta 1 uses distinct mechanisms to inhibit IFN-gamma expression in CD4+ T cells at priming and at recall: differential involvement of Stat4 and T-betQ81724302
Taming regulatory T cells by autologous T cell immunization: a potential new strategy for cancer immune therapyQ84089723
Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancerQ84174874
T helper 17 T cells do good for cancer immunotherapyQ84573840
Mechanisms of foxp3+ T regulatory cell-mediated suppressionQ29615842
PD-L1 regulates the development, maintenance, and function of induced regulatory T cellsQ30080038
CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cellsQ30480094
Sensing pathogens and tuning immune responsesQ34308011
Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.Q34504134
Control of regulatory T cell lineage commitment and maintenanceQ34658594
Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancerQ34843832
Plasticity of CD4+ T cell lineage differentiation.Q34982725
Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansionQ35125791
T(H)17 cells in tumour immunity and immunotherapy.Q35623903
Transforming growth factor beta blocks Tec kinase phosphorylation, Ca2+ influx, and NFATc translocation causing inhibition of T cell differentiationQ36370893
IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunityQ36384826
Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cellsQ36399686
Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune responseQ36402967
PD-1 and its ligands in T-cell immunityQ36791446
Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo.Q36858877
A comparison of low-dose cyclophosphamide treatment with artemisinin treatment in reducing the number of regulatory T cells in murine breast cancer model.Q39940483
Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironmentQ40130406
PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV.Q42017650
Modulation of dendritic cell function by naive and regulatory CD4+ T cellsQ42494637
Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cellsQ50095546
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectimmunizationQ1415366
P304page(s)e27289
P577publication date2011-11-08
P1433published inPLOS OneQ564954
P1476titleUp-regulation of Th17 cells may underlie inhibition of Treg development caused by immunization with activated syngeneic T cells
P478volume6

Reverse relations

cites work (P2860)
Q36024806An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.
Q51282749Clinical study of total glucosides of paeony for the treatment of diabetic kidney disease in patients with diabetes mellitus.
Q39270453Harnessing antitumor immunity: Employment of tumor recall antigens to optimize the inflammatory response to cancer
Q37360516Involvement of P2X7 receptor signaling on regulating the differentiation of Th17 cells and type II collagen-induced arthritis in mice
Q34290857Nizatidine, a small molecular compound, enhances killed H5N1 vaccine cell-mediated responses and protects mice from lethal viral challenge
Q49203850Pir-B inhibits the DC function and disturbs the Th17/Treg balance in lung cancer murine model
Q50285516The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions

Search more.